Key takeaways
- Neuralink is looking for human candidates to test its brain chip implants
- The company received FDA approval for human trials in May
- Neuralink isn’t publicly traded, but its latest funding round raised $280 million from the likes of Peter Thiel’s fund
Are the days of Terminator nearly upon us? Neuralink, Elon Musk’s human brain chip implant company, has started recruitment for human clinical trials after the business received FDA approval earlier this year in a landmark decision to make brain implants a reality.
The sci-fi-sounding company has some serious potential in the healthcare industry and marks a new frontier for the sector with brain implants, but there are still competitors out there for Neuralink to be worried about. In the meantime, though, the company’s valuation has shot up.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased